[{"Assets_0_Q3_USD":182982000.0,"CommonStockSharesOutstanding_0_Q3_shares":36032883.0,"EarningsPerShareBasic_1_Q3_USD":5.26,"EarningsPerShareBasic_3_Q3_USD":3.45,"EarningsPerShareDiluted_1_Q3_USD":5.25,"EarningsPerShareDiluted_3_Q3_USD":3.44,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-108576000.0,"NetIncomeLoss_1_Q3_USD":189073000.0,"NetIncomeLoss_3_Q3_USD":123747000.0,"StockholdersEquity_0_Q3_USD":43875000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":36047000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":35984000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":35971000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":35878000.0,"Ticker":"ISEE","CIK":"1410939","name":"OPHTHOTECH CORP.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]